( DIV/ SC, DRUG ) ( PH NO.: 35100 ) Lidocaine/ Lignocaine 1. 73- 2 Percent w/ v, Clotrimazole 1. 0 Percent Ofloxacin 0. 30 Percent w/ v Beclomethasone Dipropionate 0. 25 Percent w/ v Ear s
Secunderabad, Telangana, India
Important Dates
Bid submission started
June 25, 2024, 9:56 p.m.
Bid submission ended
July 5, 2024, 4 p.m.
Price Information
Price
Unknown
EMD
0.0
Tender Description:
Item Description: (ph no.:35100) lidocaine/lignocaine 1.73-2%w/v, clotrimazole 1.0%+ofloxacin 0.30%w/v+ beclo methasone dipropionate 0.25% w/v ear drops
Tender Type:
limited
Dates:
Published on
June 25, 2024, 9:56 p.m.
Bid Opening Date
July 5, 2024, 4 p.m.
Doc Download started
June 25, 2024, 9:56 p.m.
Doc Download ended
July 5, 2024, 4 p.m.
Documents
Sign up to access Documents
START A FREE 7-DAY TRIAL
Department & Other Tender Information
Sign up to access Tender Information
START A FREE 7-DAY TRIAL
Similar Tenders
TELANGANA
( DIV/ SC, DRUG ) ( PH NO.: 35100 ) Lidocaine/ Lignocaine 1. 73- 2 % w/ v, Clotrimazole 1. 0 % + Ofloxacin 0. 30 % w/ v + Beclomethasone Dipropionate 0. 25 % w/ v Ear drops
Expires on 05th Jul, 2024
₹ Not Specified.
ANDHRA PRADESH
CRS/ TPTY DRUG ( PH NO.: 35100 ) Lidocaine/ Lignocaine 1. 73- 2 % w/ v, Clotrimazole 1. 0 % + Ofloxacin 0. 30 % w/ v + Beclomethasone Dipropionate 0. 25 % w/ v Ear drops
Expires on 12th Jul, 2024
₹ Not Specified.
TELANGANA
Item Description: crs/ tpty drug ( ph no.: 35100 ) lidocaine/ lignocaine 1. 73- 2 % w/ v, clotrimazole 1. 0 % + ofloxac in 0. 30 % w/ v + beclomethasone dipropionate 0. 25 % w/ v ear drops
Expires on 12th Jul, 2024
₹ Not Specified.
UTTAR PRADESH
The drug contains- Neomycin 0. 5 % w/ w + Beclomethasone 0. 025 % w/ w + Clotrimazole 1 % w/ w + Lignocaine/ Lidocaine 2 % for use as ear drop packing upto 10 ml.
Expires on 15th Jul, 2024
₹ Not Specified.
UTTAR PRADESH
Item Description: the drug contains- neomycin 0. 5 % w/ w + beclomethasone 0. 025 % w/ w + clotrimazole 1 % w/ w + lignocaine/ lidocaine 2 % for use as ear drop packing upto 10 ml.
Expires on 15th Jul, 2024
₹ Not Specified.